Position in NBIX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,686,748
+$1,456,308 QoQ
Shares Held
10,008
+400.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#335
of 772 holders
Holding Since
Jun 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $10,332,357 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
57,590 | $4,591,650 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
10,008 | $1,686,748 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
20,150 | $1,288,592 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
30,000 | $1,086,000 | |
| 5 | ZTS |
Zoetis Inc.
|
12,694 | $912,190 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
22,128 | $767,177 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,686,748 | 10,008 | Shares | Sole | 2026-08-07 | |
| 2024-09-30 | $230,440 | 2,000 | Shares | Sole | 2024-11-04 | |
| 2024-03-31 | $1,392,992 | 10,100 | Shares | Sole | 2024-05-02 | |
| 2020-06-30 | $462,990 | 3,795 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||